Type
Recombinant
Description
IGF-BPscontrolthedistribution,functionandactivityofIGFsinvariouscelltissuesandbodyfluids.IGF-BP4isthemajorIGF-BPproducedbyosteoblasts,andisfoundintheepidermis,ovarianfollicles,andothertissues.IGF-BP4inhibitstheactivityofIGF-I andIGF-IIbybindinginamannerthatresultsintheformationofcomplexeswithreducedABIlitytosignalthroughcellsurfaceIGFreceptors.IGF-BP4caninhibitthegrowthofchickpelviscartilageandHT29colonadenocarcinomacellsbyblockingthemitogenicactionsofIGFs,andhasalsobeenshowntoreducecolonyformationbycolorectalcancercellsviaanIGF-independentpathway.TheBIOLOGicaleffectsofIGF-BP4canberegulatedbyPregnancyAssociatedPlasmaProteinA(PAPP-A),whichreducesIGF-BP4/IGFbindingaffinitybyproteolyticallycleavingIGF-BP4.ThemodulationofIGF-BP4activitybyPAPP-A isanimportantcomponentintheregulationofovarianfolliculogenesisandinthegrowthinhibitionofrespondingovariancancercells.RecombinantHumanIGF-BP4isa25.7 kDaproteinconsistingof237 aminoacidresiduesincluding,theIGF-BPdomainandthyroglobulintype-I domain.
AminoAcidSequence
DEAIHCPPCSEEKLARCRPPVGCEELVREPGCGCCATCALGLGMPCGVYTPRCGSGLRCYPPRGVEKPLHTLMHGQGVCMELAEIEAIQESLQPSDKDEGDHPNNSFSPCSAHDRRCLQKHFAKIRDRSTSGGKMKVNGAPREDARPVPQGSCQSELHRALERLAASQSRTHEDLYIIPIPNCDRNGNFHPKQCHPALDGQRGKCWCVDRKTGVKLPGGLEPKGELDCHQLADSFRE
Source
(BTI-Tn-5B1-4)Hi-5Insectcells*
Purity
95%
BiologicalActivity
DeterminedbyitsabilitytoinhibitIGF-I inducedproliferationofFDC-P1 cells.
Endotoxin
Endotoxinlevelis<0.1 ng/μgofprotein(<1EU/μg).
Reconstitution
Centrifugethevialpriortoopening.Reconstituteinwatertoaconcentrationof0.1–1.0 mg/ml.Donotvortex.Forextendedstorage,itisrecommendedtofurtherdiluteinabuffercontainingacarrierprotein(example0.1%BSA)andstoreinworkingaliquotsat –20°Cto –80°C.
Storage/Expiration
–20°C